[Cardiovascular complications of phosphodiesterase-5 inhibitors].

Pol Merkur Lekarski

Uniwersytet Medyczny w Lublinie, Katedra i Zakład Anatomii Prawidłowej Człowieka.

Published: February 2011

Phosphodiesterase type 5 inhibitors increase the intracellular level of cyclic guanosine monophosphate that is a potent nitric oxide dependent vasodilatation and antiproliferation agent. Unlike vardenafil and tadalafil which are prescribed in the erectile dysfunction, sildenafil is also used in a treatment of the pulmonary arterial hypertension, both congenital and acquired. The drug administration may let to various side effects such epistaxis, headache, flushing, eye problem including blurry vision, retinal hemorrhage and nonarteritic anterior ischemic optic neuropathy. It may be also complicated by high reduction of blood pressure and syncope especially in patients concomitantly treated with oral nitrate medications. High caution should be also taken in patients with a heart failure.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[cardiovascular complications
4
complications phosphodiesterase-5
4
phosphodiesterase-5 inhibitors]
4
inhibitors] phosphodiesterase
4
phosphodiesterase type
4
type inhibitors
4
inhibitors increase
4
increase intracellular
4
intracellular level
4
level cyclic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!